Envoy Medical Inc. has announced the completion of the first set of activations in the final stage of its pivotal clinical study for the investigational fully implanted Acclaim® cochlear implant. The activations took place at Shohet Ear Associates in Seal Beach, California, and the Center for Neurosciences Ear and Hearing Center in Tucson, Arizona, which are among the seven investigational sites involved in the study. No serious adverse events were reported during these initial activations. Specific hearing results from the clinical study have not yet been disclosed and will be presented after the trial is completed. Full enrollment for the pivotal trial is expected in early 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief on December 10, 2025, and is solely responsible for the information contained therein.